Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Warner-Lambert v Actavis: day one from the UK Supreme Court
Big Pharma
LSIPR attended a packed UK Supreme Court yesterday for day one of a four-day hearing, with Warner-Lambert debating the role that plausibility plays in patent law. Below we provide an overview of the case and its core issues.   13 February 2018
Americas
Global law firm Ropes & Gray has welcomed Filko Prugo to its New York office as partner and chair of the  life sciences IP practice.   12 February 2018
Merck Sharp & Dohme fails to secure new nasal spray trial
Americas
The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9.   12 February 2018
Asia-Pacific
Allergan is set to acquire Australia-based Elastagen, a clinical-stage company focused on developing medical device products based on recombinant tropoelastin, for $95 million.   12 February 2018
Americas
The US Court of Appeals for the Federal Circuit has vacated the rejection of a patent application relating to an elastic knee brace.   9 February 2018
Americas
ViiV Healthcare, which was established by major pharma companies, has filed a patent infringement complaint against Gilead Sciences in a case involving an HIV treatment drug.   9 February 2018
Big Pharma
An advocate general at the Court of Justice of the European Union yesterday backed Pfizer in a dispute over the parallel importation of an arthritis drug into Germany.   8 February 2018
Americas
Teva sued Eli Lilly yesterday in a bid to protect its IP rights covering “breakthrough treatments for migraine headaches”.   7 February 2018
Americas
The US Court of Appeals for the Federal Circuit yesterday affirmed a district court’s findings that Hospira doesn’t infringe two patents owned by biopharma firm The Medicines Company, while remanding an on-sale bar question.   7 February 2018
Asia-Pacific
AstraZeneca has announced partnerships with Chinese companies Alibaba and Tencent, in agreements that will use emerging technologies to improve healthcare in China.   6 February 2018